{"schema_version":"secwatch.filing_event.v1","accession":"0001665988-25-000013","form_type":"8-K","ticker":"BVS","cik":"0001665988","company_name":"Bioventus Inc.","filed_at":"2025-07-31T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.594496+00:00","generated_at":"2026-05-17T22:21:08.097326+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Bioventus receives FDA 510(k) clearances for TalisMann and StimTrial PNS products","bullets":["FDA granted 510(k) clearance for TalisMann PNS system with integrated pulse generator for deeper/larger nerves.","StimTrial is a trial lead to evaluate patient response, expected to aid physician adoption and payer reimbursement.","Limited commercial release in select U.S. markets in Q3 2025; broader rollout planned for early 2026.","PNS market growing >20% annually, expected to exceed $500M by 2029, representing a growth opportunity.","Company offers comprehensive PNS portfolio for chronic pain management with non-opioid, minimally invasive therapies."],"urls":{"canonical":"https://secwatch.observer/filing/0001665988-25-000013","json":"https://secwatch.observer/filing/0001665988-25-000013.json","markdown":"https://secwatch.observer/filing/0001665988-25-000013.md","text":"https://secwatch.observer/filing/0001665988-25-000013.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1665988/000166598825000013/0001665988-25-000013-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1665988/000166598825000013/bvs-20250730.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T22:21:08.097326+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}